These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
241 related articles for article (PubMed ID: 33550801)
1. Movement to the Clinic of Soluble Epoxide Hydrolase Inhibitor EC5026 as an Analgesic for Neuropathic Pain and for Use as a Nonaddictive Opioid Alternative. Hammock BD; McReynolds CB; Wagner K; Buckpitt A; Cortes-Puch I; Croston G; Lee KSS; Yang J; Schmidt WK; Hwang SH J Med Chem; 2021 Feb; 64(4):1856-1872. PubMed ID: 33550801 [TBL] [Abstract][Full Text] [Related]
4. Soluble epoxide hydrolase activity and pharmacologic inhibition in horses with chronic severe laminitis. Guedes A; Galuppo L; Hood D; Hwang SH; Morisseau C; Hammock BD Equine Vet J; 2017 May; 49(3):345-351. PubMed ID: 27338788 [TBL] [Abstract][Full Text] [Related]
5. Endoplasmic reticulum stress in the peripheral nervous system is a significant driver of neuropathic pain. Inceoglu B; Bettaieb A; Trindade da Silva CA; Lee KS; Haj FG; Hammock BD Proc Natl Acad Sci U S A; 2015 Jul; 112(29):9082-7. PubMed ID: 26150506 [TBL] [Abstract][Full Text] [Related]
7. Epoxy Fatty Acids Are Promising Targets for Treatment of Pain, Cardiovascular Disease and Other Indications Characterized by Mitochondrial Dysfunction, Endoplasmic Stress and Inflammation. McReynolds C; Morisseau C; Wagner K; Hammock B Adv Exp Med Biol; 2020; 1274():71-99. PubMed ID: 32894508 [TBL] [Abstract][Full Text] [Related]
8. Soluble epoxide hydrolase inhibition is antinociceptive in a mouse model of diabetic neuropathy. Wagner K; Yang J; Inceoglu B; Hammock BD J Pain; 2014 Sep; 15(9):907-14. PubMed ID: 24924124 [TBL] [Abstract][Full Text] [Related]
9. Preparation and evaluation of soluble epoxide hydrolase inhibitors with improved physical properties and potencies for treating diabetic neuropathic pain. Lee KSS; Ng JC; Yang J; Hwang SH; Morisseau C; Wagner K; Hammock BD Bioorg Med Chem; 2020 Nov; 28(22):115735. PubMed ID: 33007552 [TBL] [Abstract][Full Text] [Related]
10. Comparative efficacy of 3 soluble epoxide hydrolase inhibitors in rat neuropathic and inflammatory pain models. Wagner K; Inceoglu B; Dong H; Yang J; Hwang SH; Jones P; Morisseau C; Hammock BD Eur J Pharmacol; 2013 Jan; 700(1-3):93-101. PubMed ID: 23276668 [TBL] [Abstract][Full Text] [Related]
11. Modulation of mitochondrial dysfunction and endoplasmic reticulum stress are key mechanisms for the wide-ranging actions of epoxy fatty acids and soluble epoxide hydrolase inhibitors. Inceoglu B; Bettaieb A; Haj FG; Gomes AV; Hammock BD Prostaglandins Other Lipid Mediat; 2017 Nov; 133():68-78. PubMed ID: 28847566 [TBL] [Abstract][Full Text] [Related]
12. EETs/sEHi alleviates nociception by blocking the crosslink between endoplasmic reticulum stress and neuroinflammation in a central poststroke pain model. Liu T; Li T; Chen X; Li Z; Feng M; Yao W; Wan L; Zhang C; Zhang Y J Neuroinflammation; 2021 Sep; 18(1):211. PubMed ID: 34530836 [TBL] [Abstract][Full Text] [Related]
13. Omeprazole increases the efficacy of a soluble epoxide hydrolase inhibitor in a PGE₂ induced pain model. Goswami SK; Inceoglu B; Yang J; Wan D; Kodani SD; da Silva CA; Morisseau C; Hammock BD Toxicol Appl Pharmacol; 2015 Dec; 289(3):419-27. PubMed ID: 26522832 [TBL] [Abstract][Full Text] [Related]
14. Further exploration of the structure-activity relationship of dual soluble epoxide hydrolase/fatty acid amide hydrolase inhibitors. Wilt S; Kodani S; Valencia L; Hudson PK; Sanchez S; Quintana T; Morisseau C; Hammock BD; Kandasamy R; Pecic S Bioorg Med Chem; 2021 Dec; 51():116507. PubMed ID: 34794001 [TBL] [Abstract][Full Text] [Related]
15. Identification and optimization of soluble epoxide hydrolase inhibitors with dual potency towards fatty acid amide hydrolase. Kodani SD; Bhakta S; Hwang SH; Pakhomova S; Newcomer ME; Morisseau C; Hammock BD Bioorg Med Chem Lett; 2018 Feb; 28(4):762-768. PubMed ID: 29366648 [TBL] [Abstract][Full Text] [Related]
17. Optimized inhibitors of soluble epoxide hydrolase improve in vitro target residence time and in vivo efficacy. Lee KS; Liu JY; Wagner KM; Pakhomova S; Dong H; Morisseau C; Fu SH; Yang J; Wang P; Ulu A; Mate CA; Nguyen LV; Hwang SH; Edin ML; Mara AA; Wulff H; Newcomer ME; Zeldin DC; Hammock BD J Med Chem; 2014 Aug; 57(16):7016-30. PubMed ID: 25079952 [TBL] [Abstract][Full Text] [Related]